Here's What Key Metrics Tell Us About Aveanna (AVAH) Q3 Earnings

Core Insights - Aveanna Healthcare reported $621.94 million in revenue for the quarter ended September 2025, marking a year-over-year increase of 22.2% and an EPS of $0.15 compared to $0.02 a year ago, exceeding the Zacks Consensus Estimate of $0 million and showing an EPS surprise of +87.5% [1] Financial Performance Metrics - Aveanna's shares have returned +2.9% over the past month, outperforming the Zacks S&P 500 composite's +1.3% change, with a Zacks Rank 1 (Strong Buy) indicating potential for further outperformance in the near term [3] - Key metrics for Aveanna include: - Hours - PDS: 11,822.00 hours versus 11,102.22 hours estimated by two analysts on average - Revenue rate - MS: $495.43 million versus $489.43 million estimated by two analysts on average - Unique patients served (UPS) - MS: 91 versus the two-analyst average estimate of 92 - Revenue rate - PDS: $43.51 million compared to the $42.62 million average estimate based on two analysts - Revenue - PDS: $514.43 million versus the three-analyst average estimate of $473.17 million, representing a year-over-year change of +25.6% - Revenue - MS: $45.08 million versus the three-analyst average estimate of $44.63 million, representing a year-over-year change of -0.5% - Revenue - HHH: $62.43 million compared to the $59.35 million average estimate based on three analysts, representing a change of +15.3% year over year [5]